Page last updated: 2024-08-17

quinoxalines and Hyperglycemia

quinoxalines has been researched along with Hyperglycemia in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdallah, AE; Eissa, IH; ElSohly, MA; Ibrahim, MK; Metwaly, AM; Radwan, MM1
Abdi, R; Azzi, J; El Haddad, N; Elyaman, W; Fiorina, P; Jurewicz, M; Moore, RF; Mounayar, M; Petrelli, A; Ruckle, T; Takakura, A; Yang, S1
Adorjan, I; Bauer, L; Belz, M; Brunmair, B; de Cillia, VA; Fenzl, A; Frobel, K; Fürnsinn, C; Gruber, D; Lehner, Z; Luger, A; Rustenbeck, I; Stadlbauer, K1
Angel, I; Grosset, A; Langer, SZ; Perrault, G; Schoemaker, H1
García-Barrado, MJ; Moratinos, J; Palomero, J; Sancho, C1
Angel, I; Langer, SZ; Niddam, R1
Angel, I; Taranger, MA1
Angel, I; Bidet, S; Langer, SZ1

Other Studies

8 other study(ies) available for quinoxalines and Hyperglycemia

ArticleYear
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists.
    Bioorganic & medicinal chemistry, 2017, 02-15, Volume: 25, Issue:4

    Topics: Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Design; Hyperglycemia; Male; Models, Molecular; Molecular Structure; PPAR gamma; Quinoxalines; Rats; Rats, Wistar; Streptozocin; Structure-Activity Relationship; Sulfonylurea Receptors

2017
The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.
    Diabetes, 2012, Volume: 61, Issue:6

    Topics: Animals; Diabetes Mellitus, Type 1; Female; Hyperglycemia; Mice; Mice, Inbred NOD; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinoxalines; Spleen; T-Lymphocytes, Regulatory; Thiazolidinediones

2012
Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
    Diabetologia, 2012, Volume: 55, Issue:11

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Brimonidine Tartrate; Calcium; Cells, Cultured; Diabetes Mellitus, Type 2; Diazoxide; Female; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; KATP Channels; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Quinoxalines; Yohimbine

2012
In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Decerebrate State; Dioxanes; Epinephrine; Heart Rate; Hyperglycemia; Idazoxan; Indoles; Male; Mice; Motor Activity; Norepinephrine; Peripheral Nerves; Prazosin; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Vasoconstriction

1993
Role of alpha2-adrenoceptors on the hyperglycaemic and insulin secretory effects derived from alpha1- and beta-adrenoceptor stimulation in the rabbit.
    Journal of autonomic pharmacology, 1998, Volume: 18, Issue:5

    Topics: Adrenergic alpha-Agonists; Albuterol; Animals; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Ethanolamines; Heart Rate; Hyperglycemia; Insulin; Insulin Secretion; Lactic Acid; Male; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta

1998
Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Brimonidine Tartrate; Dioxanes; Dioxins; Drug Interactions; Hyperglycemia; Idazoxan; Imidazoles; Insulin; Male; Mice; Oxymetazoline; Quinoxalines; Receptors, Adrenergic, alpha

1990
Coupling between hypothalamic alpha 2-adrenoceptors and [3H]mazindol binding site in response to several hyperglycaemic stimuli in mice.
    Brain research, 1989, Jun-26, Volume: 490, Issue:2

    Topics: Animals; Binding Sites; Brimonidine Tartrate; Dioxanes; Feeding Behavior; Hyperglycemia; Hypothalamus; Idazoxan; Indoles; Male; Mazindol; Mice; Quinoxalines; Receptors, Adrenergic, alpha

1989
Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:3

    Topics: Adrenalectomy; Adrenergic alpha-Agonists; alpha-Methyltyrosine; Animals; Benzylamines; Blood Glucose; Brimonidine Tartrate; Diabetes Mellitus, Experimental; Hyperglycemia; Insulin; Male; Methyltyrosines; Mice; Quinoxalines; Reserpine

1988